Cargando…
Hyperthermic intraperitoneal chemotherapy for management of gastrointestinal and biliary tract malignancies: a systematic review and meta-analysis of randomized trials
BACKGROUND: Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) promised to transform the management of peritoneal carcinomatosis (PC). Forty years since the introduction of the technique, published data from randomized controlled trials (RCTs) remain scarce....
Autores principales: | Filis, Panagiotis, Kanellopoulou, Afroditi, Gogadis, Aristeidis, Filis, Nikolaos, Kamposioras, Konstantinos, Kapoulitsa, Fani, Mauri, Davide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hellenic Society of Gastroenterology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756031/ https://www.ncbi.nlm.nih.gov/pubmed/36593815 http://dx.doi.org/10.20524/aog.2023.0758 |
Ejemplares similares
-
Hyperthermic intraperitoneal chemotherapy (HIPEC) for the management of primary advanced and recurrent ovarian cancer: a systematic review and meta-analysis of randomized trials
por: Filis, P., et al.
Publicado: (2022) -
The Role of Hyperthermic Intraperitoneal Chemotherapy in Uterine Cancer Therapy
por: Psilopatis, Iason, et al.
Publicado: (2023) -
Side-effects of hyperthermic intraperitoneal chemotherapy in patients with gastrointestinal cancers
por: Hu, Jiyun, et al.
Publicado: (2023) -
Anesthetic implications in hyperthermic intraperitoneal chemotherapy
por: Gupta, Nishkarsh, et al.
Publicado: (2019) -
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
por: Riggs, McKayla J., et al.
Publicado: (2020)